 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
5-2-2024
Insider Buy |
Michael F. Mahoney
Director |
$54.49
CAGR »
|
$500,293.81
9,181 shares |
5-2-2024
Insider Buy |
Edward J. Ludwig
Director |
$53.88
CAGR »
|
$53,879.00
1,000 shares |
11-3-2023
Insider Buy |
Edward J. Ludwig
Director |
$70.47
CAGR »
|
$140,930.00
2,000 shares |
5-3-2023
Insider Buy |
Karen S. Lynch
President and CEO |
$69.75
CAGR »
|
$976,567.20
14,000 shares |
2-10-2022
Insider Buy |
Edward J. Ludwig
Director |
$105.90
CAGR »
|
$105,904.40
1,000 shares |
8-5-2021
Insider Buy |
Edward J. Ludwig
Director |
$79.55
CAGR »
|
$238,635.00
3,000 shares |
2-17-2021
Insider Buy |
Edward J. Ludwig
Director |
$72.00
CAGR »
|
$216,000.00
3,000 shares |
5-11-2020
Insider Buy |
Alan Lotvin
EVP and President-CVS Caremark |
$63.13
CAGR »
|
$315,675.00
5,000 shares |
3-8-2019
Insider Buy |
Edward J. Ludwig
Director |
$52.80
CAGR »
|
$105,600.00
2,000 shares |
3-8-2019
Insider Buy |
David W. Dorman
Director |
$52.71
CAGR »
|
$506,016.00
9,600 shares |
3-11-2019
Insider Buy |
C. David Brown II
Director |
$53.18
CAGR »
|
$531,800.00
10,000 shares |
3-11-2019
Insider Buy |
Fernando Aguirre
Director |
$53.59
CAGR »
|
$101,821.00
1,900 shares |
3-1-2019
Insider Buy |
Fernando Aguirre
Director |
$58.29
CAGR »
|
$198,768.90
3,410 shares |
3-1-2019
Insider Buy |
Edward J. Ludwig
Director |
$58.27
CAGR »
|
$233,080.00
4,000 shares |
5-4-2018
Insider Buy |
C. David Brown II
Director |
$61.99
CAGR »
|
$619,900.00
10,000 shares |
5-4-2018
Insider Buy |
David W. Dorman
Director |
$62.22
CAGR »
|
$1,511,868.24
24,300 shares |
7-9-2012
Insider Buy |
Stephen J. Gold
SVP & CIO |
$47.29
CAGR »
|
$450,011.64
9,516 shares |
2-13-2012
Insider Buy |
Per GH Lofberg
EVP and President, Caremark |
$42.99
CAGR »
|
$1,994,736.00
46,400 shares |
5-23-2011
Insider Buy |
Terrence Murray
Director |
$35.52
CAGR »
|
$8,523.95
240 shares |
Also See: Institutional Holders of CVS
Also See: SEC filings
Below we present the annualized performance delivered by CVS stock since 5-2-2024 (the date of the most recent
insider purchase). The performance of the investment from the time CVS insider buying occurred is the ultimate
test of whether insiders were right about CVS being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
05/03/2024 |
|
| End date: |
01/23/2025 |
|
| Start price/share: |
$55.90 |
|
| End price/share: |
$53.82 |
|
| Starting shares: |
178.89 |
|
| Ending shares: |
185.26 |
|
| Dividends reinvested/share: |
$2.00 |
|
| Total return: |
-0.29% |
|
| Annualized Gain: |
-0.40% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$9,971.00 |
|
| Years: |
0.73 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/03/2024 |
|
| End date: |
01/23/2025 |
|
| Start price/share: |
$55.90 |
|
| End price/share: |
$53.82 |
|
| Dividends collected/share: |
$2.00 |
|
| Total return: |
-0.15% |
|
| Annualized Gain: |
-0.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$9,985.00 |
|
| Years: |
0.73 |
|
CVS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent CVS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CVS
|
|
Free CVS Email Alerts:
